BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market
NEW YORK, March 18, 2025 /CNW/ - Join BMO and industry leaders in New York on March 25 for the BMO 2025 Obesity Summit to discuss the growing $150 billion obesity therapies market. The Summit features an exciting line-up of leaders in the space as well as next generation players from Altimmune, Amgen, Corbus Pharmaceuticals and Eli Lilly, to FlyteHealth, Novo Nordisk, Roman Health, Scholar Rock and Structure Therapeutics. Participants will focus on the advances in GLP-1 drug therapies and feature expert insights from pharmacy benefit managers, patients, and providers to help identify and discuss the opportunities and challenges in this market.
The BMO Obesity Summit will deliver thought leadership and corporate management perspectives in a variety of formats such as fireside chats, expert panels and presentations, including:
What: 2025 BMO Obesity Summit
When: Tuesday, March 25, 2025
Where: Convene, 360 Madison Ave, New York
Media: Register here
Discussions with leading life sciences companies hosted by BMO analysts, including Sr. Biotechnology & Pharmaceuticals Analyst, Evan Seigerman
Obesity 102 with Katherine Saunders, MD, Obesity Physician & Co-Founder, FlyteHealth
A discussion with Dr. Louis J. Aronne, M.D., Sanford I. Weill Professor of Metabolic Research
Panels on care delivery, emerging technologies, coverage and access
Insights from patients on GLP-1+ therapy
For more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There may be restrictions for media on access to some presentations.
About BMO Financial Group
BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.5 trillion as of January 31, 2025. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society.
Media contact:
Kelly Hechler, Toronto
(416) 867-3996